Pharmacists in primary care propel SUD treatment.
🧩 50% rise in medication order rates with interventions
🩺 Telemedicine effectively enhances patient treatment access
📊 Embedded referrals facilitate SUD care integration
Pharmacists in primary care propel SUD treatment.
🧩 50% rise in medication order rates with interventions
🩺 Telemedicine effectively enhances patient treatment access
📊 Embedded referrals facilitate SUD care integration
🔍 Can AI Revolutionize Urologic Cancer Care?
A systematic review assesses the role of AI in enhancing treatment strategies for urologic cancers.
🧠 Predictive Power - AI models guide treatment decisions in prostate & bladder cancer
📈 Prognostic Utility - DP-AI shows consistent value across cancer stages
📋 Clinical Integration - Needs prospective validation for routine use
📢 Enhancing readability in urological oncology summaries
The latest BRIDGE-AI 8 study showcases how AI tools, specifically Pub2Post, significantly improve the readability of layperson summaries for urological oncology trials.
🔗 Read more: [https://tnyp.me/4pnAprii/m
Readability Optimization: Outcomes from the BRIDGE-AI 8 Study:
📈 73.3±3.5 mean FRES vs. 17.0±13.1.
🔎 100% inclusion of key content.
📚 Aligned with middle-school reading level.
Enhanced readability in Urological Oncology trial layperson summaries via AI by ~76% (FRES 73.3±3.5 vs. 17.0±13.1). Achieved 100% guideline content inclusion. Simplified syntax aids comprehension.
#Pub2Post #AI #Urology #ClinicalTrials link: https://tnyp.me/4pnAprii/m
Readability Optimization in Uro-Oncology Trials: lol
📈 73.3 average readability mark
👨🏫 Middle-school reading level
✅ 100% content guideline adherence
#Pub2Post #AI #Urology #ClinicalTrials
tnyp.me/4pnAprii/m
The BRIDGE-AI 8 Study focused on improving readability in clinical trial summaries:
📝 Improved readability to FRES 73.3±3.5
📚 Aligned with middle school reading levels
🗂 Achieved 100% content inclusion
🔍 Enhanced comprehension
The BRIDGE-AI 8 Study focused on improving readability in clinical trial summaries:
📝 Improved readability to FRES 73.3±3.5
📚 Aligned with middle school reading levels
🗂 Achieved 100% content inclusion
🔍 Enhanced comprehension
📰 Breaking Barriers: Making Cancer Trials Easy to Grasp
AI tool Pub2Post simplifies trial summaries for better public understanding.
🧠 Simplified Readability - Meets middle school reading levels
🔍 Comprehensive Content - 100% guideline-defined details included
⚙️ AI Efficiency - Streamlines creation of layperson summaries
#Healthcare #AI #Pub2Post tnyp.me/4pnAprii/m #Pub2Post